Literature DB >> 27902678

Aetiology: Neighbourhood watch.

Carolyn Brown.   

Abstract

Mesh:

Substances:

Year:  2016        PMID: 27902678     DOI: 10.1038/540S4a

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  13 in total

1.  Population frequency of HLA haplotypes contributes to the prevalence difference of multiple sclerosis in Ireland.

Authors:  Christopher McGuigan; Ciaran Dunne; John Crowley; Richard Hagan; Genevieve Rooney; Eimear Lawlor; Michael Hutchinson
Journal:  J Neurol       Date:  2005-09-16       Impact factor: 4.849

2.  Prevalence of multiple sclerosis in Canada: a systematic review.

Authors:  Alexandre Y Poppe; Christina Wolfson; Bin Zhu
Journal:  Can J Neurol Sci       Date:  2008-11       Impact factor: 2.104

3.  Application of three focused cluster detection methods to study geographic variation in the incidence of multiple sclerosis in Manitoba, Canada.

Authors:  Mahmoud Torabi; Chris Green; Nancy Yu; Ruth Ann Marrie
Journal:  Neuroepidemiology       Date:  2014-10-16       Impact factor: 3.282

Review 4.  Environmental risk factors and multiple sclerosis: an umbrella review of systematic reviews and meta-analyses.

Authors:  Lazaros Belbasis; Vanesa Bellou; Evangelos Evangelou; John P A Ioannidis; Ioanna Tzoulaki
Journal:  Lancet Neurol       Date:  2015-02-04       Impact factor: 44.182

5.  Effect of high-dose vitamin D3 supplementation on antibody responses against Epstein-Barr virus in relapsing-remitting multiple sclerosis.

Authors:  Egil Røsjø; Andreas Lossius; Nada Abdelmagid; Jonas C Lindstrøm; Margitta T Kampman; Lone Jørgensen; Peter Sundström; Tomas Olsson; Linn H Steffensen; Øivind Torkildsen; Trygve Holmøy
Journal:  Mult Scler       Date:  2016-07-11       Impact factor: 6.312

6.  Prevalence, incidence, and characteristics of multiple sclerosis in Westlock County, Alberta, Canada.

Authors:  S Warren; K G Warren
Journal:  Neurology       Date:  1993-09       Impact factor: 9.910

7.  Regional variation of multiple sclerosis prevalence in Canada.

Authors:  Cynthia A Beck; Luanne M Metz; Lawrence W Svenson; Scott B Patten
Journal:  Mult Scler       Date:  2005-10       Impact factor: 6.312

8.  Vitamin D status modulates the immune response to Epstein Barr virus: Synergistic effect of risk factors in multiple sclerosis.

Authors:  Trygve Holmøy
Journal:  Med Hypotheses       Date:  2007-06-14       Impact factor: 1.538

9.  Effect of immigration on multiple sclerosis sex ratio in Canada: the Canadian Collaborative Study.

Authors:  S-M Orton; S V Ramagopalan; D Brocklebank; B M Herrera; D A Dyment; I M Yee; A D Sadovnick; G C Ebers
Journal:  J Neurol Neurosurg Psychiatry       Date:  2009-08-25       Impact factor: 10.154

10.  Vitamin D and Risk of Multiple Sclerosis: A Mendelian Randomization Study.

Authors:  Lauren E Mokry; Stephanie Ross; Omar S Ahmad; Vincenzo Forgetta; George Davey Smith; David Goltzman; Aaron Leong; Celia M T Greenwood; George Thanassoulis; J Brent Richards
Journal:  PLoS Med       Date:  2015-08-25       Impact factor: 11.069

View more
  2 in total

Review 1.  COVID-19 and Multiple Sclerosis: Predisposition and Precautions in Treatment.

Authors:  Shaghayegh Sadeghmousavi; Nima Rezaei
Journal:  SN Compr Clin Med       Date:  2020-09-03

Review 2.  Viruses and endogenous retroviruses in multiple sclerosis: From correlation to causation.

Authors:  A-F A Mentis; E Dardiotis; N Grigoriadis; E Petinaki; G M Hadjigeorgiou
Journal:  Acta Neurol Scand       Date:  2017-05-23       Impact factor: 3.209

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.